JP Patent

JP4797067B2 — Ｃ型肝炎ウイルスの大員環式阻害剤

Assigned to Janssen R&D Ireland ULC · Expires 2011-10-19 · 15y expired

What this patent protects

Patent listed against simeprevir-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
JP4797067B2
Jurisdiction
JP
Classification
—
Expires
2011-10-19
Drug substance claim
No
Drug product claim
No
Assignee
Janssen R&D Ireland ULC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.